Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SLE; Drug”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02330250
What this trial is testing

Effectiveness of Pharmaceutical Care in the Adherence of Systemic Lupus Erythematosus Treatment

Who this might be right for
Systemic Lupus ErythematosusMedication Adherence
Oswaldo Cruz Foundation 131
Testing effectiveness (Phase 2)Ended earlyNCT05879718
What this trial is testing

Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms.

Who this might be right for
Lupus Erythematosus, SystemicLupus Erythematosus, Cutaneous
Pfizer 8
Early research (Phase 1)Looking for participantsNCT06249438
What this trial is testing

C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy

Who this might be right for
Systemic Lupus Erythematosus (SLE)Immune-mediated Necrotizing Myopathy (IMNM)Neuromyelitis Optica Spectrum Disorders (NMOSD)+3 more
RenJi Hospital 30
Testing effectiveness (Phase 2)Study completedNCT04835441
What this trial is testing

ALPN-101 (Acazicolcept) in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Alpine Immune Sciences Inc, A Subsidiary of Vertex 76
Testing effectiveness (Phase 2)Study completedNCT00987831
What this trial is testing

Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Oklahoma Medical Research Foundation 158
Testing effectiveness (Phase 2)Study completedNCT05714670
What this trial is testing

The Effect of Curcumin on the Clinical Outcome of Pediatric Patients with Active Lupus Nephritis

Who this might be right for
Lupus NephritisSLE Nephritis
Ain Shams University 72
Very early researchUnknownNCT02548936
What this trial is testing

Efficacy and Safety of Simvastatin-ezetimibe Combination Therapy Among Patients With SLE

Who this might be right for
Atherosclerosis
Peking Union Medical College Hospital 30
Not applicableLooking for participantsNCT06804057
What this trial is testing

CorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry

Who this might be right for
Systemic Lupus Erythematosus
CorEvitas 1,000
Not applicableUnknownNCT01952275
What this trial is testing

Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases

Who this might be right for
Other Specified Inflammatory Disorders of Skin or Subcutaneous TissuePyoderma GangrenosumErosive Pustular Dermatosis of the Scalp+25 more
University of Zurich 600
Large-scale testing (Phase 3)Ended earlyNCT01424033
What this trial is testing

A Clinical Trial for CTD-ILD Treatment

Who this might be right for
Interstitial Lung DiseaseConnective Tissue Disease
University of Michigan 5
Early research (Phase 1)Looking for participantsNCT06977724
What this trial is testing

Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)

Who this might be right for
Dry Eye SyndromeSystemic Lupus Erythematosus
AbbVie 36
Early research (Phase 1)Looking for participantsNCT07607964
What this trial is testing

Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

Who this might be right for
Systemic Lupus ErythematosusRheumatoid Arthritis
AbbVie 30
Not applicableStudy completedNCT03370263
What this trial is testing

BENLYSTA® Special Drug Use Investigation

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 1,514
Not applicableStudy completedNCT04461158
What this trial is testing

CCCR Lupus Patient Navigator Program

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Medical University of South Carolina 75
Early research (Phase 1)Looking for participantsNCT07085104
What this trial is testing

Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Who this might be right for
Systemic Lupus Erythematosus (With and Without Nephritis)Idiopathic Inflammatory MyopathySystemic Sclerosis
Allogene Therapeutics 66
Testing effectiveness (Phase 2)Study completedNCT04643067
What this trial is testing

Phase 1b/2a Study to Evaluate Safety and Efficacy of KPG-818 in SLE

Who this might be right for
SLE; Drug
Kangpu Biopharmaceuticals, Ltd. 64
Not applicableUnknownNCT05358652
What this trial is testing

Precision Medicine in LN: A Multicenter Proof-of-concept Study for Histopathological Biomarkers Analysis in Renal Biopsy

Who this might be right for
Lupus NephritisSystemic Lupus Erythematosus
Fundacin Biomedica Galicia Sur 60
Not applicableStudy completedNCT01967472
What this trial is testing

Adherence to Antimalarial Drugs in Sierra Leone

Who this might be right for
Malaria
London School of Hygiene and Tropical Medicine 1,145
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07782450
What this trial is testing

Learn About a Medicine Called PF-08154225 in Participants With Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusRheumatoid ArthritisIdiopathic Inflammatory Myositis+1 more
Pfizer 54
Not applicableStudy completedNCT06161363
What this trial is testing

Description of Compliance With Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus
University Hospital, Toulouse 102
Next Page